Protagenic Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Protagenic Therapeutics, Inc.‘s stocks are currently a part of 6 hedge funds’ portfolios, which represents 0.02% of the total amount of its stocks outstanding. This makes up a total of 23.28K shares of Protagenic Therapeutics, Inc.. Compared to the previous quarter, the number fell by -84.77% or -129.58K shares fewer. As for the holding position changes, 133.33% (8) closed the holdings completely. 6 hedge funds are new holders of Protagenic Therapeutics, Inc. stock in Q1 2023, it is 100% of total holders.
Hedge funds holding Protagenic Therapeutics (Q3 2016 – Q1 2023)
Q3 2016 | 1 |
---|---|
Q4 2016 | 1 |
Q1 2017 | 1 |
Q2 2021 | 7 |
Q3 2021 | 13 |
Q4 2021 | 13 |
Q1 2022 | 12 |
Q2 2022 | 11 |
Q3 2022 | 12 |
Q4 2022 | 15 |
Q1 2023 | 6 |
Hedge funds changes in Protagenic Therapeutics positions (Q3 2016 – Q1 2023)
Q3 2016 | 1 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|
Q4 2016 | 0 | 0 | 0 | 0 | 1 |
Q1 2017 | 0 | 0 | 0 | 0 | 1 |
Q2 2021 | 7 | 0 | 0 | 0 | 0 |
Q3 2021 | 7 | 3 | 1 | 1 | 1 |
Q4 2021 | 3 | 4 | 2 | 3 | 1 |
Q1 2022 | 2 | 3 | 3 | 3 | 1 |
Q2 2022 | 2 | 2 | 2 | 3 | 2 |
Q3 2022 | 1 | 4 | 1 | 0 | 6 |
Q4 2022 | 4 | 2 | 4 | 1 | 4 |
Q1 2023 | 6 | 0 | 0 | 8 | -8 |
Top 50 hedge fund holders of Protagenic Therapeutics, Inc. (NASDAQ:PTIX)
Hedge fund | Value | Shares owned | Portfolio share |
---|---|---|---|
VANGUARD GROUP INC | 145K | 252.82K | 0.000% |
GEODE CAPITAL MANAGEMENT, LLC | 59K | 103.87K | 0.000% |
FNY INVESTMENT ADVISERS, LLC | 42K | 75K | 0.029% |
STATE STREET CORP | 32K | 55.24K | 0.000% |
NORTHERN TRUST CORP | 13K | 22.48K | 0.000% |
RENAISSANCE TECHNOLOGIES LLC Jim Simons | 12K | 21.02K | 0.000% |
CONCORDE ASSET MANAGEMENT, LLC | 10K | 16.71K | 0.011% |
CITADEL ADVISORS LLC Ken Griffin | 9K | 16.13K | 0.000% |
VIRTU FINANCIAL LLC | 6K | 10.58K | 0.001% |
ADVISOR GROUP HOLDINGS, INC. | 6K | 11.05K | 0.000% |
UBS GROUP AG | 4K | 6.47K | 0.000% |
TOWER RESEARCH CAPITAL LLC (TRC) | 4K | 6.52K | 0.000% |